Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-04

Clinical Trial Update: Study to Evaluate Effects of DYSPORT® Injected in Lower and Upper Limb Combined With Guided Self-Rehabilitation Contract (GSC) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effects of DYSPORT (abobotulinumtoxinA) injections in the lower and upper limbs combined with guided self-rehabilitation f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Ipsen | Conditions: Spastic Hemiparesis | Phase 4 | Status: COMPLETED | Results posted: 2019-06-04